Abstract:Background Streptococcus suis serotype 2 (SS2) is a zoonotic agent that causes death and disease in both humans and swine. A better understanding of SS2-host molecular interactions is crucial for understanding SS2 pathogenesis and immunology. Conventional genetic and biochemical approaches used to study SS2 virulence factors are unable to take into account the complex and dynamic environmental stimuli associated with the infection process. In this study, in vivo -induced antigen technology (IVIAT), an immunoscreening technique, was used to identify the immunogenic bacterial proteins that are induced or upregulated in vivo during SS2 infection. Results Convalescent-phase sera from pigs infected with SS2 were pooled, adsorbed against in vitro antigens, and used to screen SS2 genomic expression libraries. Upon analysis of the identified proteins, we were able to assign a putative function to 40 of the 48 proteins. These included proteins implicated in cell envelope structure, regulation, molecule synthesis, substance and energy metabolism, transport, translation, and those with unknown functions. The in vivo -induced changes in the expression of 10 of these 40 genes were measured using real-time reverse transcription (RT)-PCR, revealing that the expression of 6 of the 10 genes was upregulated in the in vivo condition. The strain distribution of these 10 genes was analyzed by PCR, and they were found in the most virulent SS2 strains. In addition, protein sequence alignments of the newly identified proteins demonstrate that three are putative virulence-associated proteins. Conclusion Collectively, our results suggest that these in vivo -induced or upregulated genes may contribute to SS2 disease development. We hypothesize that the identification of factors specifically induced or upregulated during SS2 infection will aid in our understanding of SS2 pathogenesis and may contribute to the control SS2 outbreaks. In addition, the proteins identified using IVIAT may be useful potential vaccine candidates or virulence markers.

Identification of three novel<i>in vivo</i>-induced expressed antigens during infection with<i>Streptococcus suis</i>serotype 2

Identification Of Three Novel In Vivo-Induced Expressed Antigens During Infection With Streptococcus Suis Serotype 2

Use of in vivo -induced antigen technology (IVIAT) for the identification of Streptococcus suis serotype 2 in vivo -induced bacterial protein antigens

Identification and Characterization of Novel Immunogenic Proteins of Streptococcus Suis Serotype 2

Immunoproteomics of Extracellular Proteins of Chinese Virulent Strains of Streptococcus Suis Type 2

Identification and Characterization of a Novel Protective Antigen, Enolase of Streptococcus Suis Serotype 2.

Identification of Immunogenic Cell Wall-Associated Proteins of Streptococcus Suis Serotype 2

Identification of Antigens Common to Streptococcus Suis Serotypes 2 and 9 by Immunoproteomic Analysis

Pre-Absorbed Immunoproteomics: A Novel Method for the Detection of Streptococcus Suis Surface Proteins

[Identification and Characterization of a Novel Infection-Related Factor (cell Wall Hydrolase/autolysin) of Streptococcus Suis Serotype 2].

Comparative Proteomic Analyses of Streptococcus Suis Serotype 2 Cell Wall-Associated Proteins

Identification of a Cell Wall-Associated Subtilisin-Like Serine Protease Involved in the Pathogenesis of Streptococcus Suis Serotype 2

Identification of Streptococcus Suis Serotype 2 Genes Preferentially Expressed in the Natural Host.

Identification of a Surface Protective Antigen, HP0197 of Streptococcus Suis Serotype 2

Characterization of IgA1 protease as a surface protective antigen of Streptococcus suis serotype 2.

Evaluation of the Protective Efficacy of Four Novel Identified Membrane Associated Proteins of Streptococcus Suis Serotype 2.

Evaluation of the Immunogenicity and the Protective Efficacy of a Novel Identified Immunogenic Protein, SsPepO, of Streptococcus Suis Serotype 2.

Identification and Characterization of IgA1 Protease from Streptococcus Suis

Immunoproteomic assay of surface proteins of Streptococcus suis serotype 9.

Evaluation of the Protective Efficacy of a Newly Identified Immunogenic Protein, HP0272, of Streptococcus Suis.

Existence and Characterization of Allelic Variants of Sao, a Newly Identified Surface Protein from Streptococcus Suis